Teva Pharmaceutical Industries (TEVA) Convertible Debt (2009 - 2010)
Teva Pharmaceutical Industries' (TEVA) quarterly Convertible Debt came in at $13.0 million in Q4 2010, down 98.41% on a YoY basis from $817.0 million in Q4 2009, and down 7.14% quarter-over-quarter from $14.0 million in Q3 2010.
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) Convertible Debt (2009 - 2010) Analysis & Trends
Teva Pharmaceutical Industries (TEVA) has reported Convertible Debt for 2 consecutive years, with $13.0 million the latest figure, recorded in Q4 2010.
- For the quarter ending Q4 2010, Convertible Debt fell 98.41% year-over-year to $13.0 million; the trailing twelve-month figure through Dec 2010 stood at $13.0 million (down 98.41% YoY), and the FY2010 full-year result was $13.0 million, down 98.41% from the prior year.
- Convertible Debt slipped to $13.0 million in Q4 2010 per TEVA's latest filing, from $14.0 million in the prior quarter.
- Across five years, Convertible Debt topped out at $1.2 billion in Q1 2009 and bottomed at $13.0 million in Q4 2010.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.56 Bn | 38.90 Bn | 2.15 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.46 Bn | 5.33 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.37 Bn | 528.25 Mn | 2.10 Bn |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 992.90 Mn | 702.78 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 411.43 Mn | 370.18 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 181.39 Mn | 181.39 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2010 | 13.00 Mn |
| Sep 30, 2010 | 14.00 Mn |
| Jun 30, 2010 | 21.00 Mn |
| Mar 31, 2010 | 47.00 Mn |
| Dec 31, 2009 | 817.00 Mn |
| Sep 30, 2009 | 832.00 Mn |
| Jun 30, 2009 | 861.00 Mn |
| Mar 31, 2009 | 1.21 Bn |